Overview of the Global Market for Medicaments Containing Corticosteroid Hormones

Market Size for Medicaments Containing Corticosteroid Hormones

The global medicaments containing corticosteroid hormones market expanded notably to $X in 2021, increasing by 5.8% against the previous year. In general, consumption, however, saw a buoyant expansion. Global consumption peaked in 2021 and is likely to see steady growth in years to come.

Production of Medicaments Containing Corticosteroid Hormones

In value terms, medicaments containing corticosteroid hormones production expanded remarkably to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +1.7% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2015 with an increase of 26% against the previous year. Global production peaked at $X in 2018; however, from 2019 to 2021, production failed to regain momentum.

Exports of Medicaments Containing Corticosteroid Hormones

Exports

For the sixth consecutive year, the global market recorded growth in overseas shipments of medicaments containing corticosteroid hormones, which increased by 2.4% to X tons in 2021. The total export volume increased at an average annual rate of +5.1% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2014 with an increase of 12%. Over the period under review, the global exports hit record highs in 2021 and are likely to continue growth in years to come.

In value terms, medicaments containing corticosteroid hormones exports rose modestly to $X in 2021. Over the period under review, total exports indicated strong growth from 2012 to 2021: its value increased at an average annual rate of +6.3% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +60.0% against 2015 indices. The growth pace was the most rapid in 2013 with an increase of 19% against the previous year. The global exports peaked in 2021 and are expected to retain growth in the immediate term.

Exports by Country

Italy (X tons), France (X tons), Germany (X tons), Belgium (X tons), India (X tons), Pakistan (X tons), Spain (X tons), the UK (X tons), China (X tons), the United States (X tons), Sweden (X tons) and the Netherlands (X tons) represented roughly 76% of total exports in 2021. Ireland (X tons) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were recorded for Pakistan (with a CAGR of +21.8%), while shipments for the other global leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing corticosteroid hormones supplying countries worldwide were Italy ($X), Germany ($X) and France ($X), together accounting for 37% of global exports. Belgium, the Netherlands, the UK, the United States, Ireland, Sweden, Spain, India, China and Pakistan lagged somewhat behind, together accounting for a further 38%.

Among the main exporting countries, Pakistan, with a CAGR of +16.0%, recorded the highest growth rate of the value of exports, over the period under review, while shipments for the other global leaders experienced more modest paces of growth.

Export Prices by Country

The average medicaments containing corticosteroid hormones export price stood at $X per ton in 2021, growing by 1.7% against the previous year. Over the last nine years, it increased at an average annual rate of +1.2%. The pace of growth appeared the most rapid in 2013 an increase of 11%. As a result, the export price reached the peak level of $X per ton. From 2014 to 2021, the average export prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was the Netherlands ($X per ton), while Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Ireland (+8.3%), while the other global leaders experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports

For the seventh consecutive year, the global market recorded growth in overseas purchases of medicaments containing corticosteroid hormones, which increased by 1.2% to X tons in 2021. Overall, total imports indicated a notable increase from 2012 to 2021: its volume increased at an average annual rate of +4.8% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +37.5% against 2013 indices. The most prominent rate of growth was recorded in 2019 when imports increased by 17%. Global imports peaked in 2021 and are expected to retain growth in the immediate term.

In value terms, medicaments containing corticosteroid hormones imports expanded sharply to $X in 2021. In general, total imports indicated buoyant growth from 2012 to 2021: its value increased at an average annual rate of +6.5% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +65.8% against 2015 indices. The growth pace was the most rapid in 2018 when imports increased by 13% against the previous year. Global imports peaked in 2021 and are expected to retain growth in years to come.

Imports by Country

In 2021, Denmark (X tons) and the United States (X tons) represented the major importers of medicaments containing corticosteroid hormonesaround the world, together amounting to near 23% of total imports. It was followed by Belgium (X tons), the UK (X tons) and China (X tons), together generating a 15% share of total imports. France (X tons), Italy (X tons), Germany (X tons), Russia (X tons), Spain (X tons), Japan (X tons), the Netherlands (X tons) and Brazil (X tons) held a minor share of total imports.

From 2012 to 2021, the biggest increases were recorded for Denmark (with a CAGR of +54.9%), while purchases for the other global leaders experienced more modest paces of growth.

In value terms, the United States ($X) constitutes the largest market for imported medicaments containing corticosteroid hormones worldwide, comprising 25% of global imports. The second position in the ranking was taken by Italy ($X), with a 7.4% share of global imports. It was followed by Belgium, with a 6.8% share.

In the United States, medicaments containing corticosteroid hormones imports increased at an average annual rate of +7.9% over the period from 2012-2021. The remaining importing countries recorded the following average annual rates of imports growth: Italy (+15.5% per year) and Belgium (+13.8% per year).

Import Prices by Country

In 2021, the average medicaments containing corticosteroid hormones import price amounted to $X per ton, picking up by 5.2% against the previous year. Over the last nine years, it increased at an average annual rate of +1.6%. The pace of growth was the most pronounced in 2014 an increase of 12%. Global import price peaked in 2021 and is expected to retain growth in the near future.

Prices varied noticeably country of destination: the country with the highest price was the United States ($X per ton), while Denmark ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Spain (+9.6%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :